Patient subgroup characterization
Describe heterogeneity within a diagnosis using symptoms, comorbidity, trajectories, treatment exposure and function.
Patient subgroup characterization
Patients who share a diagnosis may differ substantially in symptoms, comorbidity, disease course, treatment exposure, function, and risk. EVALRI uses structured phenotyping to identify clinically meaningful subgroups within this heterogeneity.
Cross-sectional and longitudinal evidence can be examined alongside a treatment’s proposed mechanism, target population, safety considerations, and intended outcome. This can support hypothesis generation, protocol design, subgroup characterization, and interpretation of treatment response.
The objective is not to infer benefit from a profile alone. Candidate subgroups and predictive features must be tested and validated in appropriately designed studies.
Explore the inferential framework
See how Ad-Infer links clinical knowledge, causal reasoning, integrated language functions and longitudinal evidence.